Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Digital Therapeutics Market, by End Use
1.4.2 Europe Digital Therapeutics Market, by Application
1.4.3 Europe Digital Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Restraints:
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Business Expansions
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Mar – 2021, Mar) Leading Players
Chapter 4. Europe Digital Therapeutics Market by End Use
4.1 Europe Patients Market by Country
4.2 Europe Providers Market by Country
4.3 Europe Payers Market by Country
4.4 Europe Employers Market by Country
4.5 Europe Other End Use Market by Country
Chapter 5. Europe Digital Therapeutics Market by Applications
5.1 Europe Diabetes Applications Market by Country
5.2 Europe CNS Disease Applications Market by Country
5.3 Europe Respiratory Diseases Applications Market by Country
5.4 Europe Smoking Cessation Applications Market by Country
5.5 Europe Obesity Applications Market by Country
5.6 Europe CVD Applications Market by Country
5.7 Europe Other Applications Market by Country
Chapter 6. Europe Digital Therapeutics Market by Country
6.1 Germany Digital Therapeutics Market
6.1.1 Germany Digital Therapeutics Market by End Use
6.1.2 Germany Digital Therapeutics Market by Applications
6.2 UK Digital Therapeutics Market
6.2.1 UK Digital Therapeutics Market by End Use
6.2.2 UK Digital Therapeutics Market by Applications
6.3 France Digital Therapeutics Market
6.3.1 France Digital Therapeutics Market by End Use
6.3.2 France Digital Therapeutics Market by Applications
6.4 Russia Digital Therapeutics Market
6.4.1 Russia Digital Therapeutics Market by End Use
6.4.2 Russia Digital Therapeutics Market by Applications
6.5 Spain Digital Therapeutics Market
6.5.1 Spain Digital Therapeutics Market by End Use
6.5.2 Spain Digital Therapeutics Market by Applications
6.6 Italy Digital Therapeutics Market
6.6.1 Italy Digital Therapeutics Market by End Use
6.6.2 Italy Digital Therapeutics Market by Applications
6.7 Rest of Europe Digital Therapeutics Market
6.7.1 Rest of Europe Digital Therapeutics Market by End Use
6.7.2 Rest of Europe Digital Therapeutics Market by Applications
Chapter 7. Company Profiles
7.1 ResMed, Inc. (Propeller Health)
7.1.1 Company Overview
7.1.1 Financial Analysis
7.1.2 Segmental and Regional Analysis
7.1.3 Research & Development Expense
7.1.4 Recent strategies and developments:
7.1.4.1 Approvals and Trials:
7.1.4.2 Partnerships, Collaborations, and Agreements:
7.2 Teladoc Health, Inc. (Livongo Health)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Recent strategies and developments:
7.2.3.1 Partnerships, Collaborations, and Agreements:
7.2.3.2 Acquisition and Mergers:
7.3 Noom, Inc.
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Partnerships, Collaborations, and Agreements:
7.4 Omada Health, Inc.
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Partnerships, Collaborations, and Agreements:
7.4.2.2 Acquisition and Mergers:
7.4.2.3 Product Launches and Product Expansions:
7.5 Welldoc, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 Canary Health
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Partnerships, Collaborations, and Agreements:
7.6.2.2 Business Expansions:
7.7 Mango Health, Inc. (TrialCard, Incorporated)
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Partnerships, Collaborations, and Agreements:
7.8 2Morrow, Inc.
7.8.1 Company Overview
7.9 Pear Therapeutics, Inc.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.9.2.2 Acquisition and Mergers:
7.9.2.3 Product Launches and Product Expansions:
7.10. Mindstrong, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
Unique Offerings 